Nasal universal vaccine shields mice from viruses, bacteria, and allergies
TL;DR
A nasal spray vaccine, GLA-3M-052-LS+OVA, protected mice against SARS-CoV-2 and other coronaviruses, guarded against certain bacteria, and reduced allergy-related lung symptoms, by engaging both innate and adaptive immunity; with three doses, it lowered lung viral loads and sped up immune responses, and human trials could begin with a target availability in 5–7 years if results translate to people.
Topics:healthscience#adaptive-immunity#innate-immunity#nasal-spray#sars-cov-2#science#universal-vaccine
- Universal Vaccine Blocks Viruses, Bacteria, And Allergies With a Nasal Spray ScienceAlert
- 'Universal' nasal-spray vaccine protects against viruses, bacteria and allergens in mice Live Science
- One vaccine may provide broad protection against many respiratory infections and allergens Stanford Medicine
- Combination nasal spray vaccine could protect against COVID, flu and pneumonia at once Fox News
- Common cold prevention: How a nose spray could be a ‘game-changer' NBC4 Washington
Want the full story? Read the original reporting
Read on ScienceAlert